http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000504343-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10 |
| filingDate | 1997-10-24^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2000-04-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2000504343-A |
| titleOfInvention | Losartan crystallization method |
| abstract | (57) [Summary] Losartan potassium (I) is an angiotensin II antagonist useful for treating hypertension and congestive heart failure. The present invention provides a controlled crystallization of losartan potassium using a combination of anti-solvent addition and bulk seeding to obtain the desired crystal morphology and bulk physical properties required for successful formulation About the law. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010510294-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002080354-A |
| priorityDate | 1996-10-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 77 of 77.